pdf
Published
2021-11-19
Issue
Section
Pharmacy Practice & Practice-Based Research
Categories
License
Copyright (c) 2021 Ife Fasina, Obed Agyei, Jennifer Kim, Ellen Montgomery, Sharon Powers, Donna Plyler
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of content published in INNOVATIONS in pharmacy belongs to the author(s).
Interprofessional Continuous Glucose Monitoring for Underserved Adults with Type 2 Diabetes on Insulin or Secretagogues
Ife Fasina
University of North Carolina Eshelman School of Pharmacy
Obed Agyei
Cone Health Internal Medicine Center, North Carolina
Jennifer Kim
Cone Health Internal Medicine Center, North Carolina
Ellen Montgomery
University of North Carolina Eshelman School of Pharmacy
Sharon Powers
Cone Health Internal Medicine Center, North Carolina
Donna Plyler
Cone Health Internal Medicine Center, North Carolina
DOI: https://doi.org/10.24926/iip.v12i4.3997
Keywords: continuous glucose monitoring, healthcare disparities, hypoglycemia risk, interprofessional patient care, type 2 diabetes, underserved patients
Abstract
Background: Literature describing continuous glucose monitoring for underserved patients, including those with type 2 diabetes or at risk for hypoglycemia, is lacking.
Methods: An interprofessional internal medicine residency team implemented a blinded CGM service for underserved adults with type 2 diabetes with at-goal glycated hemoglobin (A1C) taking insulin or secretagogues.
Results: The 2-week blinded CGM service (N=44) significantly reduced time in hypoglycemia (<70 mg/dL) by 4.1% (P=0.0038). Time-in-target-range increased significantly (4.31%, P=0.025). Body weight, number of medications, and daily insulin dose decreased significantly. Overall, A1C remained stable, indicating no worsening of diabetes control associated with the service.
Conclusions: The interprofessional blinded CGM service influenced improved glycemic control in this vulnerable population.
